by Emmitt Barry, Worthy News Correspondent
(Worthy News) – President Donald Trump announced plans to sign an executive order Monday to slash U.S. drug prices by 30% to 80% through a “Most Favored Nation” policy.
“I will be signing one of the most consequential Executive Orders in our Country’s history,” Trump posted on Truth Social. “Prescription Drug and Pharmaceutical prices will be REDUCED, almost immediately, by 30% to 80%.”
The policy would require the U.S. to pay the same price for drugs as the lowest rate offered in other countries. “For the first time in many years, bring fairness to America!” he wrote.
The America First Policy Institute (AFPI) said the move would force drugmakers to either raise prices globally or cut U.S. rates. AFPI added that the policy could pressure other countries to contribute more to pharmaceutical research.
A similar plan in 2020, aimed at tying Medicare Part B drug prices to international rates, was blocked by a federal judge after pharmaceutical companies sued.
Trump will sign the order at 9:00 A.M. Monday at the White House.
Copyright 1999-2025 Worthy News. This article was originally published on Worthy News and was reproduced with permission.
The following code is how the above article is generated with the Worthy Suite WordPress Plugin.
[worthy_plugins_news_story_body]This is how you display a story with an image.
Trump Announces Major Executive Order To Slash Drug Prices
by Emmitt Barry, Worthy News Correspondent
(Worthy News) – President Donald Trump announced plans to sign an executive order Monday to slash U.S. drug prices by 30% to 80% through a “Most Favored Nation” policy.
“I will be signing one of the most consequential Executive Orders in our Country’s history,” Trump posted on Truth Social. “Prescription Drug and Pharmaceutical prices will be REDUCED, almost immediately, by 30% to 80%.”
The policy would require the U.S. to pay the same price for drugs as the lowest rate offered in other countries. “For the first time in many years, bring fairness to America!” he wrote.
The America First Policy Institute (AFPI) said the move would force drugmakers to either raise prices globally or cut U.S. rates. AFPI added that the policy could pressure other countries to contribute more to pharmaceutical research.
A similar plan in 2020, aimed at tying Medicare Part B drug prices to international rates, was blocked by a federal judge after pharmaceutical companies sued.
Trump will sign the order at 9:00 A.M. Monday at the White House.
Copyright 1999-2025 Worthy News. This article was originally published on Worthy News and was reproduced with permission.
[worthy_plugins_news_story_title]
<div style="text-align:right; padding:0px 0px 10px 15px; float:right; width:300px;"><img src="[worthy_plugins_news_story_image name=sm_medium]" alt="" /></div>[worthy_plugins_news_story_body]